ganirelix orifarm 0.25 mg/0.5 ml
orifarm generics a/s - ganireliksacetat - injeksjonsvæske, oppløsning i ferdigfylt sprøyte - 0.25 mg/0.5 ml
xtandi
astellas pharma europe b.v. - enzalutamide - prostata neoplasmer - endokrin terapi - xtandi is indicated for:the treatment of adult men with metastatic hormone-sensitive prostate cancer (mhspc) in combination with androgen deprivation therapy (see section 5. the treatment of adult men with high-risk non-metastatic castration-resistant prostate cancer (crpc) (see section 5. the treatment of adult men with metastatic crpc who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. the treatment of adult men with metastatic crpc whose disease has progressed on or after docetaxel therapy.
bicalutamide bluefish 50 mg
bluefish pharmaceuticals ab - bikalutamid - tablett, filmdrasjert - 50 mg
buspirone orion 10 mg
orion corporation - espoo - buspironhydroklorid - tablett - 10 mg
buspirone orion 5 mg
orion corporation - espoo - buspironhydroklorid - tablett - 5 mg
carepen vet 600 mg
vetcare limited - benzylpenicillinprokainmonohydrat - intramammarie, suspensjon - 600 mg
dolovet vet 160 mg/ g
vetcare oy - ketoprofen - pulver - 160 mg/ g
zenalpha
vetcare oy - medetomidine hydrochloride, vatinoxan hydrochloride - psykoleptika, hypnotika og sedativer - hunder - to provide restraint, sedation and analgesia during conduct of non-invasive, non-painful or mildly painful procedures and examinations intended to last no more than 30 minutes.
methotrexate pfizer 25 mg/ ml
pfizer as - metotreksat - injeksjons-/infusjonsvæske, oppløsning - 25 mg/ ml
salvapar 11.25 mg
institut produits synthèse (ipsen) ab - triptorelinembonat - pulver og væske til depotinjeksjonsvæske, suspensjon - 11.25 mg